Oral Administration of Tualang and Manuka Honeys Modulates Breast Cancer Progression in Sprague-Dawley Rats Model

Table 5

The % age of histological patterns identified in TH and MH treated groups versus nontreated positive control.

Group	Total	Number of tumours (amount%)
		Benign	DCIS	Micropapillary	NOS
1; +ive control	49	2 (4.08)	3 (6.12)	4 (8.16)	40 (81.63)
2; (1.0 g/kg TH)	31	8 (25.80)	0 (0)	8 (25.80)	15 (48.38)
3; (1.0 g/kg MH)	35	2 (5.71)	0	8 (22.85)	25 (71.42)

TH: Tualang honey, MH: Manuka honey, DCIS: ductal carcinoma in situ, NOS: not-otherwise specified, and +ive control: group bearing breast cancer but received no honey treatment.